🇺🇸 FDA
Patent

US 8049015

Heteroaryl antagonists of prostaglandin D2 receptors

granted A61PA61P11/00A61P11/02

Quick answer

US patent 8049015 (Heteroaryl antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/06, A61P11/08